Advertisement
Australia markets closed

  • ALL ORDS

    8,022.70
    +28.50 (+0.36%)
     

  • ASX 200

    7,749.00
    +27.40 (+0.35%)
     

  • AUD/USD

    0.6604
    -0.0017 (-0.26%)
     

  • OIL

    78.20
    -1.06 (-1.34%)
     

  • GOLD

    2,366.90
    +26.60 (+1.14%)
     

  • Bitcoin AUD

    92,059.18
    -3,317.29 (-3.48%)
     

  • CMC Crypto 200

    1,259.29
    -98.72 (-7.27%)
     

  • AUD/EUR

    0.6128
    -0.0010 (-0.16%)
     

  • AUD/NZD

    1.0963
    -0.0006 (-0.05%)
     

  • NZX 50

    11,755.17
    +8.59 (+0.07%)
     

  • NASDAQ

    18,161.18
    +47.72 (+0.26%)
     

  • FTSE

    8,433.76
    +52.41 (+0.63%)
     

  • Dow Jones

    39,512.84
    +125.08 (+0.32%)
     

  • DAX

    18,772.85
    +86.25 (+0.46%)
     

  • Hang Seng

    18,963.68
    +425.87 (+2.30%)
     

  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     

Ukraine in talks with India on COVID-19 vaccine supply -Interfax

Reuters
·1-min read

KYIV, Jan 20 (Reuters) - Ukraine is in talks with Indian medical firm Serum Institute on supplying COVID-19 vaccines, Interfax Ukraine news agency quoted a deputy Ukrainian health minister as saying on Wednesday.

"Negotiations are underway with an Indian manufacturer, Serum Institute, which can produce the American Novovax vaccine and has the ability to produce the AstraZeneca vaccine at the moment," Interfax quoted Ihor Ivashchenko as saying.

He gave no further details.

India will initially only ship the AstraZeneca vaccine, made by The Serum Institute, the world's biggest vaccine maker, which brands the shot as COVISHIELD.

Ukraine, which registered more that 1.17 million coronavirus cases and 21,258 deaths, has already agreed to buy some vaccines from China and also expects to secure some under the global COVAX programme for poorer countries. (Reporting by Pavel Polityuk, editing by Louise Heavens)